Directory
>
Rufus Burlingame
Rufus Burlingame
VP Clinical Assay Development | Genalyte, Inc.
San Diego, California, United States
Rufus Burlingame
Summary
Rufus Burlingame is a seasoned professional in the medical equipment and supplies manufacturing industry, currently serving as the VP of Clinical Assay Development at Genalyte, Inc. With a Ph.D. in Cell Biology from Johns Hopkins University, he has a robust background in biochemistry and biotechnology, specializing in the development of multiplex assays and innovative diagnostic technologies. His career spans over two decades, during which he has successfully developed numerous FDA-cleared diagnostic assays, demonstrating his expertise in regulatory affairs and quality systems. Rufus is well-versed in a variety of laboratory techniques, including flow cytometry, PCR, and immunoassays, making him a valuable asset in the field of clinical diagnostics. He is passionate about advancing medical technologies and improving patient outcomes through innovative assay development. His leadership experience is complemented by a strong commitment to scientific excellence and collaboration in research and development.
Rufus Burlingame
Work Experience
VP Clinical Assay Development at
Genalyte, Inc.
March 2013 - Present
scientist at
Werfen
January 1998 - March 2013
Rufus Burlingame
Education
Johns Hopkins University, Doctor Of Philosophy (Ph.D.)
January 1978 - January 1984
Frequently Asked Questions about Rufus Burlingame
What is Rufus Burlingame email address?
Rufus Burlingame's primary email address is ****************@genalyte.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Rufus Burlingame work for?
Rufus Burlingame is a VP Clinical Assay Development at Genalyte, Inc., a company specializing in Surgical & medical instruments.
Where Rufus Burlingame graduated from?
Rufus Burlingame holds a degree in Cell Biology from Johns Hopkins University.
How can I directly contact Rufus Burlingame?
To contact Rufus Burlingame directly, you can use the email address ****************@genalyte.com. Complete contact information is available upon registration with Muraena.
Who is Rufus Burlingame?
Rufus Burlingame is a seasoned professional in the medical equipment and supplies manufacturing industry, currently serving as the VP of Clinical Assay Development at Genalyte, Inc. With a Ph.D. in Cell Biology from Johns Hopkins University, he has a robust background in biochemistry and biotechnology, specializing in the development of multiplex assays and innovative diagnostic technologies. His career spans over two decades, during which he has successfully developed numerous FDA-cleared diagnostic assays, demonstrating his expertise in regulatory affairs and quality systems. Rufus is well-versed in a variety of laboratory techniques, including flow cytometry, PCR, and immunoassays, making him a valuable asset in the field of clinical diagnostics. He is passionate about advancing medical technologies and improving patient outcomes through innovative assay development. His leadership experience is complemented by a strong commitment to scientific excellence and collaboration in research and development.
Rufus`s contact details
****************@genalyte.com
Colleagues
CEO and Founder
Chief Medical Officer
Vice President of Finance And Operations
Sr. Director, IVD & Clinical Regulatory
Vice President of Quality & Regulatory
Senior Vice President
Vice President of Software Engineering